Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in AVXL — Anavex Life Sciences Corp.

CIK 1705339 CAUSEWAY BAY, K3
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$109,953
-$42,939 QoQ
Shares Held
42,453
-14.8% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 179 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. AVXL ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 150,692 $74,853,236
2 REGN
Regeneron Pharmaceuticals, Inc.
 59,595 $37,159,864
3 ALNY
Alnylam Pharmaceuticals, Inc.
 63,265 $19,044,662
4 RPRX
Royalty Pharma plc
 259,390 $14,543,997
5 TWST
Twist Bioscience Corp
 100,108 $10,299,110
6 INCY
Incyte Corp
 83,084 $9,418,401
7 PRAX
Praxis Precision Medicines, Inc.
 27,185 $9,101,265
8 MRNA
Moderna, Inc.
 106,564 $7,462,676

All Filings in AVXL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $109,953 42,453
2026-03-31 $152,892 49,802
2025-12-31 $170,619 47,927
2025-09-30 $392,320 44,081
2025-06-30 $463,784 50,302
2025-03-31 $433,503 50,525
2024-12-31 $490,344 45,656
2024-09-30 $258,280 45,472
2024-06-30 $193,553 45,866